Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Update Il y a 4 ans
Reference: NCT00373048

Woman and Man

  • | Country :
  • Zambia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This is a randomized placebo controlled trial. Malaria chemoprophylaxis with mefloquine in asymptomatic HIV-infected adults living in a malaria endemic region of Luanshya, Zambia will be compared to a placebo control group and followed up for 18 months.


Inclusion criteria

  • HIV Infections

Links